Copiktra Interactions
There are 630 drugs known to interact with Copiktra (duvelisib), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 177 are major, 400 are moderate, and 53 are minor.
- View all 630 medications that may interact with Copiktra
- View Copiktra alcohol/food interactions (1)
- View Copiktra disease interactions (4)
Most frequently checked interactions
View interaction reports for Copiktra (duvelisib) and the medicines listed below.
- acetaminophen
- Adriamycin RDF (doxorubicin)
- Advate (antihemophilic factor)
- Adzenys XR-ODT (amphetamine)
- Aleve (naproxen)
- Alimta (pemetrexed)
- Allegra-D 24 Hour (fexofenadine / pseudoephedrine)
- alpha-lipoic acid
- Alphanate (antihemophilic factor/von willebrand factor)
- alprazolam
- amlodipine / hydrochlorothiazide / olmesartan
- amoxicillin / clavulanate
- Aptiom (eslicarbazepine)
- Ativan (lorazepam)
- baclofen
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Baraclude (entecavir)
- Baxdela (delafloxacin)
- Benadryl (diphenhydramine)
- Butrans (buprenorphine)
- cannabis
- Capastat (capreomycin)
- Celestone Soluspan (betamethasone)
- chlorpheniramine
- cholecalciferol
- cimetidine
- Cipro I.V. (ciprofloxacin)
- clindamycin
- Tegretol (carbamazepine)
- Valtrex (valacyclovir)
Copiktra alcohol/food interactions
There is 1 alcohol/food interaction with Copiktra (duvelisib).
Copiktra disease interactions
There are 4 disease interactions with Copiktra (duvelisib) which include:
Report options
More about Copiktra (duvelisib)
- Copiktra consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PI3K inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Ibrutinib
Ibrutinib (Imbruvica) is a Bruton's tyrosine kinase inhibitor used for certain blood cancers and ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
